Shire (SHP)

 

SHP Share PerformanceMore

52 week high5,333.0 21/09/16
52 week low3,603.5 21/08/17
52 week change -1,510.5 (-28.42%)
4 week volume56,016,898 25/08/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Miners drag on FTSE 100

Weak mining stocks and a retail sales inspired bounce in the pound weighed on the FTSE 100, which dipped to 7,276 aroun...

Shire attention deficit disorder drug meets trial results in Japan

Drug producer Shire (SHP) and its partner in Japan, Shionogi & Co announced that a Phase 3 study evaluating INTUNIV ...

Shire and Shionogi Announce Positive Topline Results for INTUNIV® Evaluated in Phase 3 Clinical Trial in Adults with ADHD

YASTEST

Broker Forecast - JP Morgan Cazenove issues a broker note on Shire PLC

JP Morgan Cazenove today reaffirms its overweight investment rating on Shire PLC (LON:SHP) and cut its price target to...

Shire Receives FDA Fast Track Designation for SHP607 for the Prevention of Chronic Lung Disease in Extremely Premature Infants

YASTEST

Shire plc : Elections for the interim dividend in respect of the six months to June 30, 2017

Shire plc: Elections for the interim dividend in respect of the six months to June 30, 2017 Elections for theinterim dividend in respect of the six months to June 30, 2017 September 11, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announced on August 3, 2017, an interim dividend of 5.09 US cents per Ordinary Share payable on October 20, 2017, to shareh...

Shire's Investigational Subcutaneous C1 esterase inhibitor (C1 INH [Human]) Liquid for Injection (SHP616) Significantly Reduces HAE Monthly Attack Rate Versus Placebo in a Phase 3 Pivotal Trial

YASTEST

Shire to participate at two upcoming investor conferences

YASTEST

Latest discussion posts More

  • Re: Telegraph- Questor

    Found this summary: "Look past the uncertainty and buy Shire for its growth and takeover prospects: Chief Executives rarely enter the debate about the performance of their ...
    3-Sep-2017
    nk1999
  • Telegraph- Questor

    http://www.telegraph.co.uk/business/2017/09/02/questor-look-past-uncertainty-buy-shire-growth-takeover-prospects/ "Questor: Look past the uncertainty and buy Shire for its ...
    3-Sep-2017
    nk1999
  • P/E 9 (cheap enough!)

    .
    24-Aug-2017
    Thedarkkn1ght

Users' HoldingsMore

Users who hold Shire also hold..
GLAXOSMITHKLINE31%
LLOYDS GRP.29%
NATIONAL GRID26%
BP24%
VODAFONE GRP.23%

Codes & Symbols

ISINJE00B2QKY057
SymbolsSHP, LSE:SHP, SHP.L, SHP:LN, LON:SHP, XLON:SHP